Is a complete NSE/PANACEABIO research report available?

No complete published report is available for nse/PANACEABIO (NSE/PANACEABIO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

NSE/PANACEABIO (NSE/PANACEABIO)

National Stock Exchange of India: NSE/PANACEABIO · INR

₹400

+11.23 (+2.9%)· Recorded snapshot

Market cap	24.4B
Revenue (ttm)	6.7B
Net income (ttm)	-71.2M
EPS (ttm)	-₹1.17
Shares out	61.3M
Volume	89,617
Beta	0.26

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 6.7B
Net income (ttm): -71.2M
EPS (ttm): -₹1.17
Market cap: 24.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-12 02:00 UTC

All NSE/PANACEABIO indicators

Market & fundamental data

Available fields

189

Groups with data

Currency

INR

Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	2,149
Employees Change	213%
Employees Change Percent	11
Enterprise value	INR 23.8B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Biotechnology
Industry PE	108.2
Industry PE Fwd	49.75
Isin	INE922B01023
Last refreshed	2026-09-12
Market cap	INR 24.4B
Price	INR 400
Price currency	INR
Rev Per Employee	3,130,013.96x
Sector	Healthcare
Sector PE	47.81
Sector PE Fwd	38.12
Sic	2836
Symbol	nse/PANACEABIO
Website	https://www.panaceabiotec.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.29%
EV/Sales	3.54x
FCF yield	-1.54%
P/B ratio	2.94x
P/S ratio	3.62x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-4.52%
EBITDA Margin	0.43%
Gross margin	54.66%
Gross Profit	INR 3.7B
Gross Profit Growth	-1.96%
Gross Profit Growth Q	9.37%
Gross Profit Growth3 Y	9.26%
Gross Profit Growth5 Y	-2.47%
Net Income	INR -71.2M
Net Income Growth Q	-43.21%
Net Income Growth Qo Q	342.31%
Net Income Growth Years	1%
Pretax Margin	-1.54%
Profit Margin	-1.06%
Profit Per Employee	INR -33,132
Profitable Quarters	INR 3
Roa5y	-2.57
Roe5y	65.98
ROIC	-3.9
Roic5y	8.23

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	13.94%
Cagr15y	7.18%
Cagr1y	-6.17%
Cagr20y	0.29%
Cagr3y	44.03%
Cagr5y	6.13%
Div CAGR3	-9.14%
Div CAGR5	-5.59%
EPS Growth Q	-42.42
EPS Growth Qo Q	375
EPS Growth Years	1
OCF Growth10 Y	-20.08%
OCF Growth5 Y	-31%
Revenue Growth	10.26x
Revenue Growth Q	19.72x
Revenue Growth Qo Q	19.68x
Revenue Growth Quarters	3x
Revenue Growth Years	3x
Revenue Growth3 Y	12.03x
Revenue Growth5 Y	1.5x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 744M
Debt	INR 236.6M
Debt EBITDA	INR 8.18
Debt Equity	INR 0.03
Debt FCF	INR -0.63
Equity	INR 8.3B
Interest Coverage	-4.77
Net Cash	INR 507.4M
Net Cash By Market Cap	INR 2.08
Net Cash Growth	-42.28%
Net Debt EBITDA	INR -17.55
Net Debt Equity	INR -0.06
Tangible Book Value	INR 7.8B
Tangible Book Value Per Share	INR 121
WACC	5.82

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.61%
Dividend per share	INR 0
Last Dividend	INR 0.75

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	268.74%
1Y total return	-6.17%
200-day SMA	400.9
3Y total return	198.88%
50-day SMA	439.4
50-day SMA vs 200-day SMA	50over200
5Y total return	34.65%
All Time High	722
All Time High Change	-44.61%
All Time High Date	2001-02-22
All Time Low	23.45
All Time Low Change	1,605.33%
All Time Low Date	2003-05-02
ATR	16.29
Beta	0.26
Beta1y	0.32
Beta2y	0.29
Ch YTD	6.27
High	400
High52	647
High52 Date	2026-06-09
High52ch	-38.19%
Low	383.5
Low52	292.4
Low52 Date	2026-03-30
Low52ch	36.77%
Ma50ch	-8.98%
Price vs 200-day SMA	-0.25%
RSI	45.95
RSI Monthly	52.41
RSI Weekly	45.51
Sharpe ratio	0.16x
Sharpe Ratio3y	0.83x
Sharpe Ratio5y	0.25x
Sortino ratio	0.39
Sortino Ratio3y	1.53
Sortino Ratio5y	0.54
Total Return	0.61%
Tr YTD	6.27
Tr15y	182.99%
Tr1m	-1.09%
Tr1w	4.89%
Tr3m	-26.89%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	15,420,710%
Shares Insiders	68.7%
Shares Institutions	0.16%
Shares Out	61,250,746
Shares Qo Q	-6.88%
Shares Yo Y	-0.61%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	111,783.95x
Bv Per Share	128.4
CAPEX	INR -540.9M
Ch10y	268.7
Ch15y	181.4
Ch1m	-1.09
Ch1w	4.89
Ch1y	-6.17
Ch20y	4.24
Ch3m	-26.89
Ch3y	198.9
Ch5y	34.65
Ch6m	13.05
Change	2.89%
Change From Open	3.09
Close	388.7
Days Gap	-0.19
Depreciation Amortization	332,715,000
Dollar Volume	35,837,838.3
Earnings Date	2026-08-13
EBIT	INR -303.8M
EBITDA	INR 28.9M
EPS	INR -1.17
F Score	2
FCF	INR -374.1M
FCF EV Yield	-1.57x
FCF Per Share	INR -6.11
Financing CF	-10,500,000
Fiscal Year End	March
Founded	1,984
Income Tax	INR -14.4M
Investing CF	-404,900,000
Is Primary Listing	1
Last Earnings Date	2026-08-13
Last Report Date	2026-06-30
Ma150	411.8
Ma150ch	-2.89%
Ma20	396.3
Ma20ch	0.91%
Net CF	-248,200,000
Next Earnings Date	2026-11-12
Open	387.9
P OCF Ratio	146
Position In Range	99.7
Price Date	2026-09-11
Price EBITDA	INR 842
Ptbv Ratio	3.11
Relative Volume	0.75x
Revenue	6,726,400,000x
Tax By Revenue	-0.21x
Tr20y	5.93%
Tr6m	13.05%
Volume	89,617

NSE/PANACEABIO (NSE/PANACEABIO)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/PANACEABIO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/PANACEABIO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on NSE/PANACEABIO

Frequently asked questions